CD4
S
tudies in a number of experimental models have demonstrated the existence of regulatory T cell populations that prevent the activation of autoreactive T cells (1) (2) (3) . The most useful marker to date for identification of regulatory T cells is the CD25 (IL-2R␣-chain) Ag that is present on 5-10% of CD4 ϩ T cells in normal animals (4 -8) . The functional properties of murine CD4 ϩ CD25 ϩ T cells have been extensively studied in vitro. They demonstrate profound anergy to stimulation via their TCR, and this anergic state cannot be reversed by costimulation with anti-CD28 (9, 10) . More importantly, when CD4 ϩ
CD25
ϩ T cells are cocultured with CD4 ϩ CD25 Ϫ T cells, they induced profound suppression of T cell activation by down-regulating IL-2 production in the responding CD4 ϩ CD25 Ϫ T cells (10) . The suppressive activity of the CD4 ϩ CD25 ϩ T cells requires that they be activated via their TCR and is cell contact dependent but cytokine independent (10, 11) .
The mechanism by which CD4 ϩ CD25 ϩ T cells mediate their suppressive effects is poorly understood. The physiologic ligand recognized by their TCR is unknown, and considerable controversy exists as to their cellular target. Thornton and Shevach (12) have demonstrated that the suppressors do not modulate APC function, whereas other laboratories have raised the possibility that they act by suppressing APC function (13) or by competing for APC-derived costimulatory signals (9) . The potential suppressive activity of CD4 ϩ
ϩ T cells on non-CD4 ϩ responder cells has not been studied in detail. Here, we demonstrate that CD4 ϩ CD25 ϩ T cells suppress CD8 ϩ T cell proliferation and IFN-␥ production induced by polyclonal or Ag-specific stimuli. In addition, the effects of the CD4 ϩ
ϩ T cells on CD8 ϩ cells are more complex than their effects on CD4 ϩ
Ϫ responders, because they suppress both IL-2 production and CD25 expression. Finally, we made use of peptide-MHC tetramers to stimulate CD8 ϩ responders in a two-cell suppressor assay system to formally demonstrate that CD4 ϩ
ϩ cells mediate their suppressor function via a T-T cell interaction and in the absence of APC.
Materials and Methods

Mice
Female C57BL/6 and BALB/c mice were obtained from the National Cancer Institute (Frederick, MD). OT-I (specific for OVA 257-264 peptide), F5 (specific for nucleoprotein (NP) 366 -374 influenza peptide), and P14 (specific for lymphocytic choriomeningitis virus (LCMV) gp33-41 peptide) CD8 ϩ TCR-transgenic (Tg) mice were obtained from Taconic Farms (Germantown, NY). All mice used were 6 -12 wk of age.
The mAbs
The following Abs were used for flow cytometry experiments: biotin-anti-CD25 (7D4 clone), FITC-streptavidin, PE-anti-CD4, PE-anti-CD8, FITCanti-CD25, FITC-anti-CD69, and purified anti-CD3⑀ (2C11), all of which were purchased from BD PharMingen (San Diego, CA). 
Tetramers
MHC class I H-2K
b -OVA 257-264 tetramer solutions were prepared at the National Institute of Allergy and Infectious Diseases tetramer facility.
Cell purification and culture
CD4
ϩ CD25 ϩ T cells were isolated on a FACStar cell sorter (BD Biosciences, San Jose, CA) as described previously (10) . The purity of the final CD4 ϩ CD25 ϩ preparation was typically Ͼ95%. T-depleted spleen cells (10; TdS) were irradiated at 3000 rad and pulsed for 30 min at 37°C with an appropriate peptide. Activated CD4 ϩ CD25 ϩ cells were prepared as previously described (12) . Briefly, cell-sorted CD4 ϩ CD25 ϩ cells were cultured with irradiated APC (1:1 ratio), anti-CD3 (0.5 g/ml), and human IL-2 (5 ng/ml, 100 U/ml) for 72 h and were then split and maintained in IL-2 medium for ϳ7-14 days. CD8 ϩ T cells were purified either by negative (depletion of B220-, CD4-, and I-A b -positive cells) or positive selection (using CD8␣ magnetic beads) on the AutoMACS magnetic separation system (Miltenyi Biotec, Auburn, CA). For experiments involving tetramer stimulation, OT-I CD8 ϩ T cells were FACS purified using Abs against Thy1.2 and CD8␣ molecules, with final purities of Ͼ99%.
Proliferation assays
Proliferation assays were performed by culturing CD8 ϩ T cells (5 ϫ 10 4 ) in flat-bottom microtiter plates (0.2 ml) with peptide-pulsed APC (1-2 ϫ 10 5 ) and resting or activated CD4 ϩ CD25 ϩ or CD4 ϩ CD25 Ϫ T cells for 72 h at 37°C in complete medium (10) . Human rIL-2 was purchased from Peprotech (Rocky Hill, NJ). Cell cultures were pulsed with [
3 H]TdR for the last 8 h. All data represent the average cpm of triplicate determinations. All proliferation experiments were repeated at least three times.
For cytokine production, supernatants were taken at 72 h, and the production of IFN-␥ was measured using an ELISA kit (R&D Systems, Minneapolis, MN).
Flow cytometry
Cells were collected and stained with PE-CD8␣ and FITC-CD69 or FITC-CD25 and analyzed with a FACScan flow cytometer (BD Biosciences).
Results and Discussion
When freshly explanted CD4 ϩ CD25 ϩ T cells from normal mice were cocultured with F5 TCR-Tg CD8 ϩ T cells, significant celldose-dependent suppression of proliferation was observed with soluble anti-CD3 as the stimulus in the presence of APC (Fig. 1A) . When the TCR-Tg cells were stimulated with specific peptide, no inhibition of proliferation was observed (data not shown). When activated CD4
ϩ CD25 ϩ T cells from normal mice were used, marked suppression of proliferation of F5 CD8 ϩ TCR-Tg T cells was observed with peptide stimulation (Fig. 1C) . This finding confirms previous studies (12) using CD4 ϩ T cells as responders in which the CD4 ϩ CD25 ϩ T cells required activation via their TCR to manifest suppressor function, but following activation, suppressor effector function was Ag-nonspecific and did not require restimulation of the suppressors via their TCR.
Because CD8
ϩ T cells will produce significant amounts of IFN-␥ in the absence of previous priming, we next studied the effects of CD4 ϩ CD25 ϩ T cells on the capacity of CD8 ϩ T cells to produce IFN-␥. Freshly explanted CD4 ϩ
CD25
ϩ T cells readily suppressed IFN-␥ production by CD8 ϩ T cells stimulated with anti-CD3 (Fig. 1B) , and activated CD4 ϩ CD25 ϩ T cells suppressed IFN-␥ production when the CD8 ϩ T cells were stimulated with specific peptide (Fig. 1D) . We have consistently shown Ͼ50% suppression of both proliferation and IFN-␥ secretion at a CD25 ϩ : CD8 ratio of 1:2, and Ͼ75% suppression at a 1:1 cell ratio. CD4 ϩ CD25 ϩ T cells (Fig. 1, A and C) cultured alone do not proliferate and do not secrete IFN-␥ (data not shown). CD4 ϩ CD25 Ϫ T cells (Fig. 1C) cultured in the absence of CD8 ϩ T cells do not produce IFN-␥ (data not shown).
IL-2 will reverse suppression when CD4 ϩ CD25 ϩ suppressors are cocultured with CD4 ϩ
Ϫ responders. It has been proposed that IL-2 can directly act on the suppressors and reverse their anergic phenotype and consequently disable their suppressive capability (14) . Alternatively, the addition of exogenous IL-2 may simply be circumventing the block in IL-2 production induced in the responders by the CD4 ϩ
ϩ suppressors. When fresh CD4 ϩ CD25 ϩ T cells ( Fig. 2A) or activated CD4 ϩ CD25 ϩ T cells (Fig. 2B) were cocultured with OT-I CD8 ϩ T cells, significant suppression of proliferation (ϳ60%) and IFN-␥ production ( 1138 CUTTING EDGE: CD4 ϩ CD25 ϩ REGULATORY T CELLS Suppression was not reversed by the addition of exogenous IL-2 at all suppressor:responder ratios or by enhancement of endogenous IL-2 production by the addition of anti-CD28 (data not shown).
Increasing the amount of IL-2 added to the cocultures to 100 U/ml also had no effect. 
ϩ T cells to the proliferative responses in the cocultures performed in the presence of IL-2 is also minimal but may contribute some residual proliferation to the culture. The hypothesis (9) that IL-2 abrogates suppressor function is not supported by our studies on CD8 ϩ responders because suppression is clearly maintained in the presence of IL-2.
We next examined the expression of CD25 on F5 CD8 ϩ T cells stimulated either in the presence or absence of CD4 ϩ CD25 ϩ T cells. Following 6 h of stimulation with peptide-pulsed APC, upregulation of CD25 expression on the F5 CD8 ϩ T cell responders was similar in presence or absence of CD4 ϩ CD25 ϩ T cells (Fig.  3A) . However, no further up-regulation of CD25 on the CD8 ϩ responders was seen in the CD4 ϩ CD25 ϩ /CD8 ϩ cocultures (Fig.  3A) . The expression of CD69 was identical on CD8 ϩ responders stimulated in the presence or absence of CD4 ϩ CD25 ϩ cells at both time points tested (Fig. 3A) . In multiple (n ϭ 5) experiments, addition of activated CD4 ϩ CD25 ϩ T cells resulted in 73 Ϯ 5% suppression of the induction of CD25 when the responding CD8 ϩ T cells were assayed for CD25 expression following 24 h of stimulation. The addition of exogenous IL-2 (100 U/ml) also failed to restore the level of CD25 expression on suppressed responders to levels seen on responders cultured alone (Fig. 3B ) or responders cultured with activated CD4 ϩ
Ϫ T cells (data not shown). Soluble tetramer stimulation of OT-I CD8 ϩ T cells resulted in robust T cell proliferation (Fig. 4A) and IFN-␥ production (Fig.  4B) , confirming previous studies (15) (16) (17) showing that CD8 ϩ T cells can be efficiently activated in the absence of APC and APCderived costimulatory signals. CD8 ϩ T cells from normal C57BL/6 mice did not proliferate at any tetramer concentration (Fig. 4A) , nor did an irrelevant soluble tetramer (H-2D b /CEA antigenic peptide) preparation induce proliferation (data not shown) or IFN-␥ production (Fig. 4B) . To directly assess whether CD4 ϩ CD25 ϩ T cells suppress CD8 ϩ T cell responders by modulating APC function or by direct T-T contact, we stimulated highly purified OT-I CD8 ϩ T cells (Ͼ99% pure) with soluble MHC I H-2K b -OVA 257-264 tetramers, in the presence or absence of titrated numbers of CD4 ϩ CD25 ϩ T cells. Marked suppression of both proliferation and IFN-␥ production was seen in the pres-
ϩ :CD8 ϩ ratios (Fig. 4, C and D) . Taken together, the results from this two-cell system conclusively demonstrate that CD4 ϩ CD25 ϩ -mediated suppression occurs via a T-T cell interaction, and the APC is not directly required for the delivery of the suppressive signal to responding CD8 ϩ T cells. CD8 ϩ T cells may contribute to the immunopathogenesis of many autoimmune diseases (18 -21) . Therefore, it is desirable that regulatory T cells be able to control autoreactive CD8 ϩ T cells as well as CD4 ϩ T cells. Most of the effects of regulatory CD4 ϩ CD25 ϩ T cells on CD8 ϩ responders were similar to those seen with CD4 ϩ responders. However, several important differences should be noted. First, in addition to T cell proliferation, the capacity of fresh CD8 ϩ T cells to manifest effector function such as the production of IFN-␥ was also suppressed. Second, whereas CD4 ϩ CD25 ϩ T cells inhibit the activation of CD4 ϩ responders by primarily blocking IL-2 production, CD4 ϩ
ϩ T cells regulate 
CD8
ϩ T cell responses both by blocking IL-2 production as well as by lowering responsiveness to exogenous IL-2 and thereby potentially disrupting CD4 help for CD8 ϩ T cells. Finally, CD4 ϩ CD25 ϩ T cells can inhibit T cell activation by directly acting on responder CD8 ϩ T cells in the absence of APC. However, this result does not exclude the possibility that CD4 ϩ CD25 ϩ T cells might also exert inhibitory/deactivating effects on APC or use the APC surface as a platform on which the suppressor cells physically interact with CD4 ϩ or CD8 ϩ effectors in vivo.
Although immunoregulatory CD4
ϩ CD25 ϩ cells function beneficially in vivo to protect the host against the development of autoimmunity, they may simultaneously prevent the host from mounting an immune response to autoantigens such as tumor Ags. Because IL-2 responsiveness by CD8 ϩ T cells is a critical factor for cytokine production (IFN-␥) and cytolytic activity (22, 23) , our demonstration that CD4 ϩ CD25 ϩ T cells down-regulate both IL-2 production and CD25 expression on CD8 ϩ T cells may represent a significant impediment to the use of tumor or viral vaccines. Indeed, deletion of CD4 ϩ CD25 ϩ T cells before the use of such vaccines may be needed for optimal immunotherapy.
